Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:43:21.762Z.
Calculation as of: 2026-10-06T19:43:21.762Z.
Quote observation: 2026-10-06T19:27:35.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d6bc5587bb9f90acc5d4b17d4ca5e7b82419962628673aeee65b4bef0dd46512
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
SciSparc Ltd.
Market Cap
$246973.00
Price/FCF Ratio
N/A
Market Cap
$28295.00
Price/FCF Ratio
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO |
|---|---|---|
| SciSparc Ltd. (SPRC) | $246973.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $356454.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71190.00 | N/A |
| Akanda Corp. (AKAN)vs › | $60201.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30997.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $28295.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
